Identification of ataxia telangiectasia heterozygotes, a cancer-prone population, using the single-cell gel electrophoresis (Comet) assay

Laboratory Investigation

Volumn 79, Issue 6, 1999, Pages 699-705

  Djuzenova, Cholpon S ^a   Schindler, Detlev ^a   Stopper, Helga ^a   Hoehn, Holger ^a   Flentje, Michael ^a   Oppitz, Ulrich ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATAXIA TELANGIECTASIA; CANCER RADIOTHERAPY; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GEL ELECTROPHORESIS; HETEROZYGOTE DETECTION; HIGH RISK POPULATION; HUMAN; IN VITRO STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; RADIOSENSITIVITY;

EID: 0033019278     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. 2 chromosomal radiosensitivity in ataxia telangiectasia lymphocytes. Mutat Res 152:39-47.
2. Bentzen SM (1997). Potential clinical impact of normal-tissue intrinsic radiosensitivity testing. Radiother Oncol 43:121-131.
3. Chen P, Farell A, Hobson K, Girjes A, and Lavin M (1994). Comparative study of radiation-induced G2 phase delay and chromatid damage in families with ataxia-telangiectasia. Cancer Genet Cytogenet 76:43-46.
4. Chen PC, Lavin MF, and Kidson C (1978). Identification of ataxia telangiectasia heterozygotes, a cancer prone population. Nature 274:484-486.
5. Klaude M, Eriksson S, Nygren J, and Ahnström G (1996). The comet assay: Mechanisms and technical considerations. Mutat Res 363:89-96.
6. 2 chromosomal radiosensitivity in fibroblasts of ataxia telangiectasia heterozygotes and a Li-Fraumeni syndrome patient with radioresistant cells. Int J Radiat Biol 72:435-438.
7. Nachtrab U, Oppitz U, Flentje M, and Stopper H (1998). Radiation-induced micronucleus formation in human skin fibroblasts of patients showing severe and normal tissue damage after radiotherapy. Int J Radiat Biol 73:279-287.
8. 2/M before and after γ-irradiation. Mod Pathol 7:587-592.
9. Natarajan AT, Meijers M, van Zeeland AA, and Simons JWIM (1982). Attempts to detect ataxia telangiectasia (AT) heterozygotes by cytogenetical techniques. Cytogenet Cell Genet 33:145-151.
10. Olive PL, Banáth JP, and Durand RE (1990). Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the "comet" assay. Radiat Res 122:86-94.
11. Ramsay J, Birrel G, and Lavin M (1998). Testing for mutations of the ataxia telangiectasia gene in radiosensitive breast cancer patients. Radiother Oncol 47:125-128.
12. Sanford KK, Parshad R, Price FM, Jones GM, Tarone RE, Eierman L, Hale P, and Waldmann TA (1990). Enhanced chromatid damage in blood lymphocytes after G2 phase × irradiation, a marker of the ataxia-telangiectasia gene. J Natl Cancer Inst 82:1050-1054.
13. 60Co γ-irradiation in vitro. Int J Radiat Biol 70:521-527.
14. Scott D, Jones LA, Elyan SAG, Spreadborough A, Cowan R, and Ribiero G (1993). Identification of A-T heterozygotes. In: Gatti RA and Painter RB, eds. Ataxia Telangiectasia. Berlin-Heidelberg: Springer-Verlag, 101-116.
15. Seyschab H, Schindler D, Friedl R, Barbi G, Bolthauser E, Fryns JP, Hanefeld F, Korinthenberg R, Krägeloh-Mann I, Scheres JMJC, Schinzel A, Seemanová E, Tommerup N, and Hoehn H (1992). Simultaneous measurement, using flow cytometry, of radiosensitivity and defective mitogen response in ataxia telangiectasia and related syndromes. Eur J Pediatr 151:756-760.
16. Shiloh Y (1995). Ataxia telangiectasia: Closer to unraveling the mystery. Eur J Hum Genet 3:116-138.
17. Shiloh Y, Parshad R, Frydman M, Sandford KK, Portnoi S, Ziu Y, and Jones GM (1989). G2 chromosomal radiosensitivity in families with ataxia-telangiectasia. Hum Genet 84:15-18.
18. Shiloh Y, Parshad R, Sanford KK, and Jones GM (1986). Carrier detection in ataxia-telangiectasia. Lancet 1:689-690.
19. Singh NP, McCoy MT, Tice RR, and Schneider EL (1988). A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175:184-191.
20. Swift M, Morrell D, Massey RB, and Chase CL (1991). Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325:1831-1836.
21. Swift M, Reitnauer PJ, Morrell D, and Chase CL (1987). Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 316:11289-1294.
22. 2 phase chromosomal radio-sensitivity of peripheral blood lymphocytes. Hum Genet 101:312-316.
23. Telatar M, Teraoka S, Wang Z, Chun HH, Liang T, Castellvi-Bel S, Udar N, Borresen-Dale A, Chessa L, Bernatowska-Matuszkiewicz E, Porras O, Watanabe M, Junker A, Concannon P, and Gatti RA (1998). Ataxia-telangiectasia: Identification and detection of founder-effect mutations in the ATM gene in ethnic populations. Am J Hum Genet 62:86-97.
24. Weeks DE, Paterson MC, Lange K, Andrais B, Davis RC, Yoder F, and Gatti RA (1991). Assessment of chronic γ-radiosensitivity as an in vitro assay for heterozygote identification of ataxia-telangiectasia cells. Radiat Res 128:90-99.
25. West CML, Elyan SAG, Berry P, Cowan R, and Scott D (1995). A comparison of the radiosensitivity of lymphocytes from normal donors, cancer patients, individuals with ataxia-telangiectasia (A-T) and A-T heterozygotes. Int J Radiat Biol 68:197-203.